Israel (TASE:ILCO) Reports Stronger Earnings, Is The Valuation Discount Justified?

Israel Corporation earnings event in focus

Israel Corporation (TASE:ILCO) has drawn investor attention after reporting second quarter 2026 results that included higher sales, net income and earnings per share compared with the same period in 2025.

The company also pointed to a higher net cash position, a dividend payout of about US$13 million and a 10 to 1 share split, along with portfolio activity related to Prodalim's February 2026 IPO.

See our latest analysis for Israel.

At a share price of ₪80.25, Israel has seen short term momentum pick up, with a 1 month share price return of 6.18%. However, the share price is still down 12.79% year to date, and the 1 year total shareholder return has declined 22.15%. This may suggest that the latest earnings and balance sheet news are prompting investors to reassess both growth potential and risks.

If Israel's recent move has you rethinking your watchlist, this can be a good moment to broaden your search and check out 102 top founder-led companies

Bulls see Israel's stronger earnings, cash position and shareholder payouts as a fresh base for value. Bears point to the multi year share price decline. Does the current valuation better fit a recovery story or a value trap?

Price to earnings of 17.8x for Israel, is it justified?

Israel is trading on a P/E of 17.8x based on recent earnings, which is below both its directly assessed peer group on 41.8x and the wider Asian Chemicals industry on 21.2x. That gap sits alongside a share price of ₪80.25 that has fallen over longer time frames, so the key question is whether the earnings underpinning this multiple are steady enough for investors to treat the discount as meaningful.

The P/E multiple compares the current share price to the company’s earnings per share. For a business like Israel that operates across potash, phosphate solutions, industrial products and growing solutions, investors often look at the P/E to gauge how the market is weighing its earnings against sector peers that face similar commodity cycles, capital intensity and pricing conditions.

According to Simply Wall St’s checks, Israel scores as “good value” on this preferred metric. The stock trades at 17.8x earnings versus a 41.8x peer average and a 21.2x Asian Chemicals industry average, even though the company is currently profitable, has what is described as high quality earnings, and has only recently become profitable across the past five years. That combination suggests the market is assigning a lower multiple to those earnings than to many comparable chemicals companies.

Against the broader Asian Chemicals industry on 21.2x, Israel’s 17.8x P/E represents a clear discount. Against its more focused peer set on 41.8x, the gap is even wider. If those earnings hold up, there is room for investors to question whether this level of underpricing relative to both groups is justified or whether it reflects concerns that are not captured in the headline multiple.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price to earnings of 17.8x (UNDERVALUED)

However, Israel still faces risks if commodity pricing shifts or fertilizer demand weakens, which could pressure earnings and keep the current P/E discount in place.

Find out about the key risks to this Israel narrative.

Another view on Israel Corporation's valuation

While Israel looks inexpensive on a 17.8x P/E compared with peers, the SWS DCF model points the other way. At a current price of ₪80.25 and an estimated future cash flow value of ₪28.40, the stock screens as overvalued using this cash flow lens. Which signal do you trust more for the long term?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Israel for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 257 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Uncertain about whether Israel is a potential opportunity or a value trap after these mixed valuation signals and risk flags? Take a closer look at the underlying data, then weigh the 1 important warning sign.

Looking for more investment ideas beyond Israel?

Israel's latest results may have sharpened your focus. Do not stop there. Use this moment to refresh your watchlist with other informed ideas that fit your style.

• Target dependable income streams by reviewing companies in the 440 dividend fortresses that may help anchor your portfolio with regular payouts.
• Spot potential mispriced opportunities by scanning the 257 high quality undervalued stocks that combine solid fundamentals with room for investors to reassess expectations.
• Prioritise resilience by checking out the 303 resilient stocks with low risk scores that aim to limit downside while still keeping you exposed to equity market upside.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com